Free Trial

Innovative Eyewear (LUCYW) 10K Form and Latest SEC Filings 2026

Innovative Eyewear logo
$0.05 +0.00 (+1.12%)
As of 03:59 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Latest Innovative Eyewear SEC Filings & Recent Activity

Innovative Eyewear (NASDAQ:LUCYW) has submitted 154+ documents to the U.S. Securities and Exchange Commission (SEC) since 2020. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form 144 submitted on April 7, 2026.

10-K
Innovative Eyewear Files Annual Report on Mar. 25, 2026

The 10-K contains Innovative Eyewear's audited financial statements, revenue, earnings, and risk factors for the prior fiscal year.

View earnings history

Innovative Eyewear SEC Filing History

Browse Innovative Eyewear's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
04/07/2026 10:35 AM
Gross Harrison R. (1906224) Reporting
Innovative Eyewear (1808377) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2026 3:50 PM
Abondano Joaquin (2008020) Reporting
Innovative Eyewear (1808377) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2026 3:37 PM
Cohen David Eric (1911813) Reporting
Innovative Eyewear (1808377) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2026 1:57 PM
Gayle Oswald (2042078) Reporting
Innovative Eyewear (1808377) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2026 3:05 PM
Innovative Eyewear (1808377) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2026 3:44 PM
Innovative Eyewear (1808377) Subject
INTRACOASTAL CAPITAL, LLC (1646799) Filed by
Form SCHEDULE 13G/A
02/05/2026 4:24 PM
Chapman Kelly Joseph (2106872) Filed by
Innovative Eyewear (1808377) Subject
Form SCHEDULE 13G/A
01/22/2026 5:16 PM
Chapman Kelly Joseph (2106872) Filed by
Innovative Eyewear (1808377) Subject
Form SCHEDULE 13G
01/22/2026 10:29 AM
Gross Harrison R. (1906224) Reporting
Innovative Eyewear (1808377) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2026 4:00 PM
Gayle Oswald (2042078) Reporting
Innovative Eyewear (1808377) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2026 4:00 PM
Dabrowski Konrad (1906013) Reporting
Innovative Eyewear (1808377) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2026 4:00 PM
Gross Harrison R. (1906224) Reporting
Innovative Eyewear (1808377) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2026 5:05 AM
Gross Harrison R. (1906224) Reporting
Innovative Eyewear (1808377) Issuer
Form 5
Annual statement of changes in beneficial ownership of securities  
01/09/2026 7:24 PM
Cohen David Eric (1911813) Reporting
Innovative Eyewear (1808377) Issuer
Form 5
Annual statement of changes in beneficial ownership of securities  
01/09/2026 6:17 PM
Gayle Oswald (2042078) Reporting
Innovative Eyewear (1808377) Issuer
Form 5
Annual statement of changes in beneficial ownership of securities  
01/09/2026 6:19 PM
Dabrowski Konrad (1906013) Reporting
Innovative Eyewear (1808377) Issuer
Form 5
Annual statement of changes in beneficial ownership of securities  
01/09/2026 6:23 PM
Abondano Joaquin (2008020) Reporting
Innovative Eyewear (1808377) Issuer
Form 5
Annual statement of changes in beneficial ownership of securities  
01/07/2026 8:45 PM
Galkin Vladimir (2020621) Filed by
Innovative Eyewear (1808377) Subject
Form SCHEDULE 13D/A
01/07/2026 8:44 PM
Galkin Vladimir (2020621) Reporting
Innovative Eyewear (1808377) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2026 3:35 PM
Innovative Eyewear (1808377) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2026 3:18 PM
Galkin Vladimir (2020621) Filed by
Innovative Eyewear (1808377) Subject
Form SCHEDULE 13D/A
01/02/2026 3:20 PM
Galkin Vladimir (2020621) Reporting
Innovative Eyewear (1808377) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2025 3:28 PM
Galkin Vladimir (2020621) Filed by
Innovative Eyewear (1808377) Subject
Form SCHEDULE 13D/A
12/29/2025 12:49 PM
Galkin Vladimir (2020621) Reporting
Innovative Eyewear (1808377) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2025 10:53 AM
Galkin Vladimir (2020621) Reporting
Innovative Eyewear (1808377) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2025 2:19 PM
Galkin Vladimir (2020621) Reporting
Innovative Eyewear (1808377) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2025 2:25 PM
Galkin Vladimir (2020621) Filed by
Innovative Eyewear (1808377) Subject
Form SCHEDULE 13D/A
12/08/2025 11:35 AM
Galkin Vladimir (2020621) Reporting
Innovative Eyewear (1808377) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2025 4:26 PM
Innovative Eyewear (1808377) Subject
INTRACOASTAL CAPITAL, LLC (1646799) Filed by
Form SCHEDULE 13G/A
10/16/2025 3:30 PM
Innovative Eyewear (1808377) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2025 11:38 AM
Cohen David Eric (1911813) Reporting
Innovative Eyewear (1808377) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/24/2025 10:46 AM
Gayle Oswald (2042078) Reporting
Innovative Eyewear (1808377) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2025 1:40 PM
Cohen David Eric (1911813) Reporting
Innovative Eyewear (1808377) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/27/2025 6:45 PM
Innovative Eyewear (1808377) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2025 12:17 PM
Abondano Joaquin (2008020) Reporting
Innovative Eyewear (1808377) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2025 12:22 PM
Dabrowski Konrad (1906013) Reporting
Innovative Eyewear (1808377) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2025 12:12 PM
Gross Harrison R. (1906224) Reporting
Innovative Eyewear (1808377) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2025 9:58 AM
Gayle Oswald (2042078) Reporting
Innovative Eyewear (1808377) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2025 10:02 AM
Cohen David Eric (1911813) Reporting
Innovative Eyewear (1808377) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2025 4:00 PM
Innovative Eyewear (1808377) Filer
Form 424B5
08/15/2025 4:01 PM
Innovative Eyewear (1808377) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2025 11:15 PM
Innovative Eyewear (1808377) Filer
Form EFFECT
07/18/2025 4:01 PM
Innovative Eyewear (1808377) Filer
Form S-1
Registration statement under Securities Act of 1933  
07/14/2025 3:05 PM
Innovative Eyewear (1808377) Filer
Form DEF 14A
06/24/2025 3:30 PM
Innovative Eyewear (1808377) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2025 11:15 PM
Innovative Eyewear (1808377) Filer
Form EFFECT
(Data available from 1/1/2016 forward)

Innovative Eyewear SEC Filings - Frequently Asked Questions

Innovative Eyewear (LUCYW) has submitted 154+ filings to the SEC since 2020. You can browse the complete history or filter by form type using the tools above.

The most recent filing was a Form 144 submitted on April 7, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:LUCYW) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners